Toward an Understanding of Frailty
Authors: David Hamerman
Journal: Annals of Internal Medicine (1999)

Medical Writings1 June 1999Toward an Understanding of FrailtyDavid Hamerman, MDDavid Hamerman, MDAlbert Einstein College of Medicine; Bronx, NY 10467 (Hamerman)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-130-11-199906010-00022 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Health care providers who serve an aging population inherently associate the word frailty with patients whom they perceive as frail. Although frailty is not confined to elderly persons, it is more frequently observed in persons older than 85 years of age (the "oldest old") (1). This is because limitations and diseases associated with aging are an inseparable part of frailty (2-5). As a result, frailty remains more a constellation of many conditions than a discrete clinical entity, and it certainly does not have a precise scientific meaning (6). Frailty is often identified by words that express a similar state, such ...References1. Suzman RM, Manton KG, Willis DP. Introducing the oldest old.. In: Suzman RM, Willis DP, Manton KC, eds. The Oldest Old. New York: Oxford Univ Pr; 1992:3-14. Google Scholar2. Fried LP. Frailty. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:1149-55. Google Scholar3. Powell C. Frailty: help or hindrance? J R Soc Med. 1997;90 Suppl 23-36. CrossrefMedlineGoogle Scholar4. van Weel C, Michels J. Dying, not old age, to blame for costs of health care. Lancet. 1997;350:1159-60. CrossrefMedlineGoogle Scholar5. Fried LP, Williamson JD, Kaspar J. The epidemiology of frailty: scope of the problem.. In: Perry HM 3d, Morley JE, Coe RM, eds. Aging and Musculoskeletal Disorders: Concepts, Diagnosis, and Treatment. New York: Springer; 1993:3-15. Google Scholar6. Buchner DM, Wagner EH. Preventing frail health. Clin Geriatr Med. 1992;8:1-17. CrossrefMedlineGoogle Scholar7. Brown I, Renwick R, Raphael D. Frailty: constructing a common meaning, definition, and conceptual framework. Int J Rehabil Research. 1995;18:93-102. CrossrefMedlineGoogle Scholar8. Speechley M, Tinetti M. Falls and injuries in frail and vigorous community elderly persons. J Am Geriatr Soc. 1991;339:46-52. CrossrefGoogle Scholar9. Strawbridge WJ, Shema SJ, Balfour JL, Higby HR, Kaplan GA. Antecedents of frailty over three decades in an older cohort. J Gerontol. 1998;53B:S9-16. CrossrefGoogle Scholar10. Winograd CH, Gerety MB, Chung M, Goldstein MK, Dominguez F, Vallone R. Screening for frailty: criteria and predictors of outcomes. J Am Geriatr Soc. 1991;39:778-84. CrossrefMedlineGoogle Scholar11. Rockwood K. Medical management of frailty: confessions of a gnostic. CMAJ. 1997;157:1081-4. MedlineGoogle Scholar12. Hébert R. Functional decline in old age. CMAJ. 1997;157:1037-45. MedlineGoogle Scholar13. Gealey SG. Quantification of the term frail as applied to the elderly client. J Am Acad Nurse Pract. 1997;9:505-10. CrossrefMedlineGoogle Scholar14. Fretwell MD. Acute hospital care for frail older patients. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:241-8. Google Scholar15. Rockwood K, Fox RA, Stolee P, Robertson D, Beattie BL. Frailty in elderly people: an evolving concept. CMAJ. 1994;150:489-95. MedlineGoogle Scholar16. Gill TM, Robison JT, Tinetti ME. Difficulty and dependence: two components of the disability continuum among community-living older persons. Ann Intern Med. 1998;128:96-101. LinkGoogle Scholar17. Egbert AM. "The dwindles." Failure to thrive in older patients. Postgrad Med. 1993;94:199-201, 204-6, 210-2. Google Scholar18. Evans WJ. What is sarcopenia? J Gerontol A Biol Sci Med Sci. 1995; 50 Spec No:5-8. Google Scholar19. Roubenoff R, Harris TB. Failure to thrive, sarcopenia and functional decline in the elderly. Clin Geriatr Med. 1997;13:613-22. CrossrefMedlineGoogle Scholar20. Hildebrand JK, Joos SK, Lee MA. Use of the diagnosis "failure to thrive" in older veterans. J Am Geriatr Soc. 1997;45:1113-7. CrossrefMedlineGoogle Scholar21. Sarkisian CA, Lachs MS. "Failure to thrive" in older adults. Ann Intern Med. 1996;124:1072-8. LinkGoogle Scholar22. Verdery RB. Failure to thrive in old age: follow-up on a workshop. J Gerontol A Biol Sci Med Sci. 1997;52:M333-6. CrossrefMedlineGoogle Scholar23. Verdery RB. Failure to thrive. In: Hazzard WR, Bierman EL, Blass JP, Ettinger WH Jr, Halter JB, eds. Principles of Geriatric Medicine and Gerontology. 3d ed. New York: McGraw-Hill; 1994:1205-11. Google Scholar24. Fox KM, Hawkes WG, Magaziner J, Zimmerman SI, Hebel JR. Markers of failure to thrive among older hip fracture patients. J Am Geriatr Soc. 1996;44:371-6. CrossrefMedlineGoogle Scholar25. Verdery RB. Failure to thrive in older people. J Am Geriatr Soc. 1996;44:465-6. CrossrefMedlineGoogle Scholar26. Fried LP, Guralnik JM. Disability in older adults: evidence regarding significance, etiology, and risk. J Am Geriatr Soc. 1997;45:92-100. CrossrefMedlineGoogle Scholar27. Gonski PN. Acopia—a new DRG? Med J Aust. 1997;167:421-2. CrossrefMedlineGoogle Scholar28. Clark LP, Dion DM, Barker WH. Taking to bed. Rapid functional decline in an independently mobile older population living in an intermediate-care facility. J Am Geriatr Soc. 1990;38:967-72. CrossrefMedlineGoogle Scholar29. Wallace JI, Schwartz RS, LaCroix AZ, Uhlmann RF, Pearlman RA. Involuntary weight loss in older outpatients: incidence and clinical significance. J Am Geriatr Soc. 1995;43:329-37. CrossrefMedlineGoogle Scholar30. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr. 1997;127:1014-6S. CrossrefGoogle Scholar31. Moldawer LL, Copeland EM. Proinflammatory cytokines, nutritional support, and the cachexia syndrome: interactions and therapeutic options. Cancer. 1997;79:1828-39. CrossrefMedlineGoogle Scholar32. Gray-Donald K. The frail elderly: meeting the nutritional challenges. J Am Diet Assoc. 1995;95:538-40. CrossrefMedlineGoogle Scholar33. Matthys P, Billiau A. Cytokines and cachexia. Nutrition. 1997;13:763-70. CrossrefMedlineGoogle Scholar34. Isaacs B, Gunn J, McKechan A, McMillan I, Neville Y. The concept of pre-death. Lancet. 1971;1:1115-8. CrossrefMedlineGoogle Scholar35. Jarrett PG, Rockwood K, Carver D, Stollee P, Cosway S. Illness presentation in elderly patients. Arch Intern Med. 1995;155:1060-4. CrossrefMedlineGoogle Scholar36. Resnick NM, Marcantonio ER. How should clinical care of the aged differ? Lancet. 1997;350:1157-8. CrossrefMedlineGoogle Scholar37. Ory MG, Schechtman KB, Miller JP, Hadley EC, Fiatarone MA, Province MA, et al . Frailty and injuries in later life: the FICSIT trials. J Am Geriatr Soc. 1993;41:283-96. CrossrefMedlineGoogle Scholar38. Hadley EC, Ory MG, Suzman R, Weindruch R, Fried L, eds. Physical frailty. A treatable cause of dependence in old age. Proceedings of a symposium. Minneapolis, Minnesota, 18 November 1989. J Gerontol. 1993; 48 Spec No:3-88. Google Scholar39. Brody KK, Johnson RE, Douglas Reid L. Evaluation of a self-report screening instrument to predict frailty outcomes in aging populations. Gerontologist. 1997;37:182-91. CrossrefMedlineGoogle Scholar40. Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS. Price of adaptation—allostatic load and its health consequences. MacArthur studies of successful aging. Arch Intern Med. 1997;157:2259-68. CrossrefMedlineGoogle Scholar41. Czaja SJ, Weber RA, Nair SN. A human factor analysis of ADL activities: a capability-demand approach. J Gerontol. 1993; 48 Spec No:44-8. Google Scholar42. Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, et al . A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49:M85-94. CrossrefMedlineGoogle Scholar43. Guralnik JM. Assessment of physical performance and disability in older persons. Muscle Nerve Suppl. 1997;5:S14-6. CrossrefMedlineGoogle Scholar44. Williamson JD, Fried LP. Targeting disabled and at risk older adults for inclusion in population based studies. Muscle Nerve Suppl. 1997;5:S21-6. CrossrefMedlineGoogle Scholar45. Branch LG, Meyers AR. Assessing physical function in the elderly. Clin Geriatr Med. 1987;3:29-51. CrossrefMedlineGoogle Scholar46. Reuben DB. Warning signs along the road to functional dependency [Editorial]. Ann Intern Med. 1998;128:138-9. LinkGoogle Scholar47. Mulrow CD, Gerety MB, Cornell JE, Lawrence VA, Kanten DN. The relationship between disease and function and perceived health in very frail elders. J Am Geriatr Soc. 1994;42:374-80. CrossrefMedlineGoogle Scholar48. Ritchie CS, Burgio KL, Locher JL, Cornwell A, Thomas D, Hardin M, et al . Nutritional states of urban homebound older adults. Am J Clin Nutr. 1997;66:815-8. CrossrefMedlineGoogle Scholar49. Harrison JF. The politics of disability: some implications for geriatricians. J R Soc Med. 1997;90 Suppl 32 5-10. CrossrefMedlineGoogle Scholar50. Schulz R, Williamson GM. Psychosocial and behavioral dimensions of physical frailty. J Gerontol. 1993; 48 Spec No:39-43. Google Scholar51. Katz IR, DiFilippo S. Neuropsychiatric aspects of failure to thrive in late life. Clin Geriatr Med. 1997;13:623-38. CrossrefMedlineGoogle Scholar52. Kim SH, Wolde-Tsadik G, Reuben DB. Predictors of perceived health in hospitalized older persons: a cross-sectional and longitudinal study. J Am Geriatr Soc. 1997;45:420-6. CrossrefMedlineGoogle Scholar53. Frisoni GB, Franzoni S, Rozzini R, Ferrucci L, Boffelli S, Trabucchi M. Food intake and mortality in the frail elderly. J Gerontol A Biol Sci Med Sci. 1995;50A:M203-10. CrossrefGoogle Scholar54. Markson EW. Functional, social, and psychological disability as causes of loss of weight and independence in older community-living people. Clin Geriatr Med. 1997;13:639-52. CrossrefMedlineGoogle Scholar55. Rosenthal AJ, Sanders KM, McMurtry CT, Jacobs MA, Thompson DD, Gheorghiu D, et al . Is malnutrition overdiagnosed in older hospitalized patients? Association between the soluble interleukin-2 receptor and serum markers of malnutrition. J Gerontol A Biol Sci Med Sci. 1998;53:M81-6. CrossrefMedlineGoogle Scholar56. Wagner EH. Preventing decline in function. Evidence from randomized trails around the world. West J Med. 1997;167:295-8. MedlineGoogle Scholar57. Brown K, Boot D, Groom L, Williams E. Problems found in the over-75s by the annual health check. Br J General Pract. 1997;47:31-5. MedlineGoogle Scholar58. Williamson J, Stokoe IH, Gray S, Fisher M, Smith A, McGhee A, et al . Old people at home. Their unreported needs. Lancet. 1964;1:1117-20. CrossrefMedlineGoogle Scholar59. Rubenstein LZ. Documenting impacts of geriatric consultation [Editorial]. J Am Geriatr Soc. 1987;35:829-30. CrossrefMedlineGoogle Scholar60. Rubenstein LZ, Josephson KR, Wieland GD, English PA, Sayre JA, Kane RL. Effectiveness of a geriatric evaluation unit: a randomized clinical trail. N Engl J Med. 1984;311:1664-70. CrossrefMedlineGoogle Scholar61. Fries JF. Aging, illness, and health policy: implications of the compression of morbidity. Perspect Biol Med. 1988;31:407-28. CrossrefMedlineGoogle Scholar62. Verbrugge LM. Longer life but worsening health? Trends in health and mortality of middle-aged and older persons. Milbank Mem Fund Q Health Soc. 1984;62:475-519. CrossrefMedlineGoogle Scholar63. Olshansky SJ, Cassel CK. Implications of the accrual of chronic nonfatal conditions in very elderly persons.. In: Hamerman D, eds. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:15-29. Google Scholar64. Boult C, Altmann M, Gilbertson D, Yu C, Kane RL. Decreasing disability in the 21st century: the future effects of controlling six fatal and nonfatal conditions. Am J Public Health. 1996;86:1388-93. CrossrefMedlineGoogle Scholar65. Manton KG, Corder LS, Stallard E. Monitoring changes in the health of the U.S. elderly population: correlates with biomedical research and clinical innovations. FASEB J. 1997;11:923-30. CrossrefMedlineGoogle Scholar66. Hochberg MC. Epidemiologic considerations in the primary prevention of osteoarthritis. J Rheumatol. 1991;18:1438-40. MedlineGoogle Scholar67. Hamerman D. The aging skeleton—osteoarthritis and osteoporosis.. In: Hamerman D, eds. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:99-121. Google Scholar68. Raisz LG. The osteoporosis revolution. Ann Intern Med. 1997;126:458-62. LinkGoogle Scholar69. Roses AD. Genetic testing for Alzheimer disease. Practical and ethical issues. Arch Neurol. 1997;54:1226-9. CrossrefMedlineGoogle Scholar70. Behl C. Amyloid β-protein toxicity and oxidative stress in Alzheimer's disease. Cell Tissue Res. 1997;290:471-80. CrossrefMedlineGoogle Scholar71. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, et al . Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation. 1997;96:526-34. CrossrefMedlineGoogle Scholar72. Tritos NA, Mantzoros CS. Recombinant human growth hormone: old and novel uses. Am J Med. 1998;105:44-57. CrossrefMedlineGoogle Scholar73. Bartke A, Brown-Borg HM, Bode AM, Carlson J, Hunter WS, Bronson RT. Does growth hormone prevent or accelerate aging? Exp Gerontol. 1998;33:675-87. CrossrefMedlineGoogle Scholar74. Lamberts SW, van den Beld AW, van der Lely AJ. The endocrinology of aging. Science. 1997;278:419-24. CrossrefMedlineGoogle Scholar75. Lieberman SA, Hoffman AR. The somatopause: should growth hormone deficiency in older people be treated? Clin Geriatr Med. 1997;13:671-84. CrossrefMedlineGoogle Scholar76. Toogood AA, O'Neill PA, Shalet SM. Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. J Clin Endocrinol Metab. 1996;81:460-5. MedlineGoogle Scholar77. Bunn PA Jr. Cancer and acquired immunodeficiency syndrome wasting syndromes: current and future therapies. Semin Oncol. 1998; 25(2 Suppl 6):1-3. Google Scholar78. DeBlaauw I, Deutz NEP, von Meyenfeldt MF. Metabolic changes in cancer cachexia. Clin Nutr. 1997;16:223-8. CrossrefMedlineGoogle Scholar79. Rowe JW, Kahn RL. Successful aging. Gerontologist. 1997;37:433-40. CrossrefMedlineGoogle Scholar80. Hazzard WR. Ways to make "usual" and "successful" aging synonymous. Preventive gerontology. West J Med. 1997;167:206-15. MedlineGoogle Scholar81. Campisi J. Aging and cancer: the double-edged sword of replicative senescence. J Am Geriatr Soc. 1997;45:482-8. CrossrefMedlineGoogle Scholar82. Granville DJ, Carthy CM, Hunt DW, McManus BM. Apoptosis: molecular aspects of cell death and disease. Lab Invest. 1998;78:893-913. MedlineGoogle Scholar83. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev. 1998;78:547-81. CrossrefMedlineGoogle Scholar84. Lithgow GJ, Kirkwood TB. Mechanisms and evolution of aging. Science. 1996;273:80. CrossrefMedlineGoogle Scholar85. Ershler WB. Interleukin-6: a cytokine for gerontologists. J Am Geriatr Soc. 1993;41:176-81. CrossrefMedlineGoogle Scholar86. Mysliwska J, Bryl E, Foerster J, Mysliwski A. Increase of interleukin 6 and decrease of interleukin 2 production during the ageing process are influenced by the health status. Mech Ageing Develop. 1998;100:313-28. CrossrefMedlineGoogle Scholar87. Barton BE. IL-6: insights into novel biological activities. Clin Immunol Immunopathol. 1997;85:16-20. CrossrefMedlineGoogle Scholar88. Holden RJ, Pakula IS. The role of tumor necrosis factor-α in the pathogenesis of anorexia and bulimia nervosa, cancer cachexia and obesity. Med Hypotheses. 1996;47:423-38. CrossrefMedlineGoogle Scholar89. Dutta C, Hadley EC, Lexell J. Sarcopenia and physical performance in old age: overview. Muscle Nerve Suppl. 1997;5:S5-9. CrossrefMedlineGoogle Scholar90. Marcus R. Relationship of age-related decreases in muscle mass and strength to skeletal status. J Gerontol A Biol Sci Med Sci. 1995; 50 Spec No:86-7. Google Scholar91. Cannon JG. Cytokines in aging and muscle homeostasis. J Gerontol A Biol Sci Med Sci. 1995; 50 Spec No:120-3. Google Scholar92. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS. The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J Gerontol A Biol Sci Med Sci. 1997; 52 Spec No:M201-8. Google Scholar93. Dentino AN, Pieper CF, Rao KM, Currie MS, Harris T, Blazer DG, et al . Association of interleukin-6 and other biologic variables with depression in older people living in the community. J Am Geriatr Soc. 1999;47:6-11. CrossrefMedlineGoogle Scholar94. Ashcroft GS, Horan MA, Ferguson MW. Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Invest. 1998;78:47-58. MedlineGoogle Scholar95. Manolagas SC. Pathophysiologic role of interleukin-6 in osteoporosis and other bone diseases, pp 132-3. In: Papanicolaou DA, moderator. The pathophysiologic roles of interleukin-6 in human diseases. Ann Intern Med. 1998; 128:127-37. Google Scholar96. Streckfus CF, Johnson RB, Nick T, Tsao A, Tucci M. Comparison of alveolar bone loss, alveolar bone density and second metacarpal bone density, salivary and gingival crevicular fluid interleukin-6 concentrations in healthy premenopausal and postmenopausal women on estrogen therapy. J Gerontol A Biol Sci Med Sci. 1997;52:M343-51. CrossrefMedlineGoogle Scholar97. Richards CD, Gauldie J. Role of cytokines in acute-phase response.. In: Aggarwal BA, Puri RK, eds. Human Cytokines: Their Role in Disease and Therapy. Cambridge, MA: Blackwell Science; 1995:253-70. Google Scholar98. Spector TD, Hart DJ, Nandra D, Doyle DV, Mackillop N, Gallimore JR, et al . Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease. Arthritis Rheum. 1997;40:723-7. CrossrefMedlineGoogle Scholar99. Tracy RP, Lemaitre RN, Psaty BM, Ives DG, Evans RW, Cushman M, et al . Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol. 1997;17:1121-7. CrossrefMedlineGoogle Scholar100. Ridker PM, Glynn RJ, Hennekens CH. C-reactive protein adds to the predictive value of total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998;97:2007-11. CrossrefMedlineGoogle Scholar101. Ballou SP, Kushner I. Chronic inflammation in older people: recognition, consequences, and potential intervention. Clin Geriatr Med. 1997;13:653-69. CrossrefMedlineGoogle Scholar102. Bristow MR. Tumor necrosis factor-α and cardiomyopathy [Editorial]. Circulation. 1998;97:1340-1. CrossrefMedlineGoogle Scholar103. Sridhar MK. Why do patients with emphysema lose weight? Lancet. 1995;345:1190-1. CrossrefMedlineGoogle Scholar104. Bonnefoy M, Coulon L, Bienvenu J, Boisson RC, Rys L. Implication of cytokines in the aggravation of malnutrition and hypercatabolism in elderly patients with severe pressure sores. Age Ageing. 1995;24:37-42. CrossrefMedlineGoogle Scholar105. Sternberg EM. Neural-immune interactions in health and disease. J Clin Invest. 1997;100:2641-7. CrossrefMedlineGoogle Scholar106. Seeman TE, Robbins RJ. Aging and the hypothalamic-pituitary-adrenal response to challenge in humans. Endocr Rev. 1994;15:233-60. MedlineGoogle Scholar107. Mobbs CV. Neuroendocrinology of aging. In: Schneider EL, Rowe JW, eds. Handbook of the Biology of Aging. 4th ed. San Diego: Academic Pr; 1996; 234-82. Google Scholar108. Rothwell N, Allan S, Toulmond S. The role of interleukin 1 in acute neurodegeneration and stroke: pathophysiological and therapeutic implications. J Clin Invest. 1997;100:2648-52. CrossrefMedlineGoogle Scholar109. Papanicolaou DA. Molecular biology of interleukin-6, pp 127-30. In: Papanicolaou DA, moderator. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med. 1998; 128:127-37. Google Scholar110. Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L. Leptin selectively decreases visceral adiposity and enhances insulin action. J Clin Invest. 1997;100:3105-10. CrossrefMedlineGoogle Scholar111. Cefalu WT, Werbel S, Bell-Farrow AD, Terry JG, Wang ZQ, Opara EC, et al . Insulin resistance and fat patterning with aging: relationship to metabolic risk factors for cardiovascular disease. Metabolism. 1998;47:401-8. CrossrefMedlineGoogle Scholar112. Morin CL, Pagliassotti MJ, Windmiller D, Eckel RH. Adipose tissue-derived tumor necrosis factor-α activity is elevated in older rats. J Gerontol A Biol Sci Med Sci. 1997;52:B190-5. CrossrefMedlineGoogle Scholar113. Grunfeld C, Zhao C, Fuller J, Pollack A, Moser A, Friedman J, et al . Endotoxin and cytokines induce expression of leptin, the ob gene product, in hamsters. J Clin Invest. 1996;97:2152-7. CrossrefMedlineGoogle Scholar114. Kirchgessner TG, Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Tumor necrosis factor-α contributes to obesity-related hyperleptinemia by regulating leptin release from adipocytes. J Clin Invest. 1997;100:2777-82. CrossrefMedlineGoogle Scholar115. Bessesen DH, Faggioni R. Recently identified peptides involved in the regulation of body weight. Semin Oncol. 1998; 25(2 Suppl 6):28-32. Google Scholar116. Auwerx J, Staels B. Leptin. Lancet. 1998;351:737-42. CrossrefMedlineGoogle Scholar117. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: the tale of an obesity gene. Diabetes. 1996;45:1455-62. CrossrefMedlineGoogle Scholar118. Orban Z, Bornstein SR, Chrousos GP. The interaction between leptin and the hypothalamic-pituitary-thyroid axis. Horm Metab Res. 1998;30:231-5. CrossrefMedlineGoogle Scholar119. Li H, Matheny M, Nocolson M, Tümer N, Scarpace PJ. Leptin gene expression increases with age independent of increasing adiposity in rats. Diabetes. 1997;46:2035-9. CrossrefMedlineGoogle Scholar120. Ostlund RE, Yang JW, Klein S, Gingerich R. Relation between plasma leptin concentration and body fat, gender, diet, age, and metabolic covariates. J Clin Endocrinol Metab. 1996;81:3909-13. MedlineGoogle Scholar121. Andersen RE, Blair SN, Cheskin LJ, Bartlett SJ. Encouraging patients to become more physically active: the physician's role. Ann Intern Med. 1997;127:395-400. LinkGoogle Scholar122. Vita AJ, Terry RB, Hubert HB, Fries JF. Aging, health risks, and cumulative disability. N Engl J Med. 1998;338:1035-41. CrossrefMedlineGoogle Scholar123. Lee IM, Paffenbarger RS, Hennekens CH. Physical activity, physical fitness and longevity. Aging Clin Exp Res. 1997;9:2-11. CrossrefGoogle Scholar124. Tseng BS, Marsh DR, Hamilton MT, Booth FW. Strength and aerobic training attenuate muscle wasting and improve resistance to the development of disability with aging. J Gerontol. 1995;50A:113-9. CrossrefGoogle Scholar125. Weindruch R, Sohol RS. Seminars in medicine of the Beth Israel Deaconess Medical Center. Caloric intake and aging. N Engl J Med. 1998;337:986-94. CrossrefGoogle Scholar126. Diplock AT. Antioxidant nutrients and disease prevention: an overview. Am J Clin Nutr. 1991;53 1 Suppl 189-93S. Google Scholar127. Cauley JA, Seeley DG, Browner WS, Ensrud K, Kuller LH, Lipschutz RC, et al . Estrogen replacement therapy and mortality among older women. The Study of Osteoporotic Fractures. Arch Intern Med. 1997;157:2181-7. CrossrefMedlineGoogle Scholar128. Morley JE, Kaiser FE, Sih R, Hajjar R, Perry HM. Testosterone and frailty. Clin Geriatr Med. 1997;13:685-95. CrossrefMedlineGoogle Scholar129. Ghiron LJ, Thompson JL, Holloway L, Hintz RL, Butterfield GE, Hoffman AR, et al . Effects of recombinant insulin-like growth factor-I and growth hormones on bone turnover in elderly women. J Bone Miner Res. 1995;10:1844-52. CrossrefMedlineGoogle Scholar130. Oriander PR, Nader S. Endocrinology. Youthful hormones. Lancet. 1996;348 Suppl 2 II6. CrossrefGoogle Scholar131. Borst SE, Millard WJ, Lowenthal DT. Growth hormone, exercise, and aging: the future of therapy for the frail elderly. J Am Geriatr Soc. 1994;42:528-35. CrossrefMedlineGoogle Scholar132. Shetty KR, Gupta KL, Rudman D. New clinical applications for recombinant human growth hormone.. In: Buckwalter JA, Goldberg VM, Woo SL, eds. Musculoskeletal Soft-Tissue Aging: Impact on Mobility. Rosemont, IL: American Academy of Orthopaedic Surgeons; 1993:61-72. Google Scholar133. Ravaglia G, Forti P, Maioli F, Boschi F, Bernardi M, Pratelli L, et al . The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. J Clin Endocrinol Metab. 1996;81:1173-8. MedlineGoogle Scholar134. Casson PR, Carson SA, Buster JE. Replacement dehydroepiandrosterone in the elderly: rationale and prospects for the future. Endocrinologist. 1998;8:187-94. CrossrefGoogle Scholar135. Koopman WJ, Moreland LM. Rheumatoid arthritis: anticytokine therapies on the horizon. Ann Intern Med. 1998;128:231-3. LinkGoogle Scholar136. Pugh-Humphreys RG, Thomson AW. Cytokines and their receptors as potential therapeutic targets. In: Thomson AW, ed. The Cytokine Handbook. 2d ed. San Diego: Academic Pr; 1994:525-66. Google Scholar137. Arend WP, Malyak M, Guthridge CJ, Gabay C. Interleukin-1 receptor antagonist: role in biology. Annu Rev Immunol. 1998;16:27-55. CrossrefMedlineGoogle Scholar138. Pate RR, Pratt M, Blair SN, Haskell WL, Macera CA, Bouchard C, et al . Physical activity and public health. A recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402-7. CrossrefMedlineGoogle Scholar139. Hamerman D. Aging and the musculoskeletal system. Ann Rheum Dis. 1997;56:578-85. CrossrefMedlineGoogle Scholar140. Judge JO. The principles and prescription of exercise for frail older persons.. In: Hamerman D, eds. Osteoarthritis: Public Health Implications for an Aging Population. Baltimore: Johns Hopkins Univ Pr; 1997:125-49. Google Scholar141. Rowe JW. The new gerontology [Editorial]. Science. 1997;278:367. CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Albert Einstein College of Medicine; Bronx, NY 10467 (Hamerman)Acknowledgments: The author thanks Drs. Nir Barzilai and Jomarie Zeleznik for helpful discussions and Dawn Bowen-Jenkins for preparation of the manuscript.Corresponding Author: Dr. David Hamerman, Resnick Gerontology Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467 PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe impact of late-career job loss and genetic risk on body mass index: Evidence from variance polygenic scoresEffect of the combination of automated peripheral mechanical stimulation and physical exercise on aerobic functional capacity and cardiac autonomic control in patients with Parkinson's disease: a randomized clinical trial protocolPatient assessment and feasibility of treatment in older patients with cancer: results from the IN-GHO® RegistryThe conceptual and practical definitions of frailty in older adults: a systematic reviewState-of-the-art surgery for sigmoid diverticulitisReview of frailty measurement of older people: Evaluation of the conceptualization, included domains, psychometric properties, and applicabilityThe new older adult participant in American politicsAssociations Between Polypharmacy and Gait Speed According to Cognitive Impairment Status: Cross-Sectional Study in a Japanese Memory ClinicFifteen years change in acute management of hip fracture patients: 1-year mortality calls for improvementsUtility of Frailty Assessment in Urologic Stone Surgery: A Review of the LiteratureSurgical Considerations for Older Adults With Cancer: A Multidimensional, Multiphase Pathway to Improve CareDevelopment of a Motility Frailty Index in Patients with GastroparesisThe effect of frailty on postoperative readmissions, morbidity, and mortality in endometrial cancer surgeryA novel approach for the design of context-aware services for social inclusion and educationMoving towards a better identification and management of frailty in ICU survivorsFrailty: Past, present, and future?Geriatrisches Assessment: Personalisierung des alten TumorpatientenBiological aspects of aging that influence response to anticancer treatmentsOne-year mortality increases four-fold in frail patients undergoing cardiac surgeryFrailtyThe Effect of Aging Physiology on Critical CareMinimally Invasive Aortic Valve Surgery in Octogenarians: Reliable Option or Fallback Solution?Utility of Liver Transplantation Within the Bounds of Non-futilityFrailty as a predictor of future falls in hospitalized patients: A systematic review and meta-analysisValidation of Psoas Muscle Index as a predictor of successful extubation in elderly intensive care patients: a retrospective cohort studyOperationalization of Concepts of Health and DisabilityIntegrating Geriatric Oncology into Clinical Pathways and GuidelinesExercise Interventions in Dialysis PatientsChronic Kidney Disease in the Elderly—Who Has It? Who Does One Treat? and How are They to be Treated?Frailty and Sarcopenia in Patients With Distal Radius Fracture: A Geriatric PerspectiveManagement of The Elderly Cancer Patients Complexity: The Radiation Oncology PotentialFrailty prevalence and agreement between assessment tools in elderly patients of Western IndiaWie lassen sich Ressourcen und Defizite bei älteren Tumorpatienten einschätzen?Association of the age-adjusted Charlson Comorbidity Index and systemic inflammation